Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00377416Early Phase 1Completed
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency
Alpha 1-Antitrypsin Deficiency
Principalinvestigator
NCT00430768Phase 1Completed
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency
Alpha 1-Antitrypsin Deficiency
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

UMass Medical School

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen Wisniewski, PhD

University of Pittsburgh

Moderately Similar
4 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score30%

Zachary Peggs

The University of Nottingham

Moderately Similar
1 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency
Similarity Score30%

Igor Barjakatarevic, MD

Ronald Reagan UCLA Medical Center, Santa Monica, CA, USA

Moderately Similar
1 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency
Similarity Score30%

Jeanine M D'Armiento, MD, PhD

Columbia University

Moderately Similar
1 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency

Worked with same sponsors:

Alpha-1 FoundationNational Heart, Lung, and Blood Institute (NHLBI)
Similarity Score30%

Charlton Strange, MD

Medical University of South Carolina, Charleston, SC, USA

Moderately Similar
2 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency
Similarity Score30%

Nabeel Y Hamzeh, MD

National Jewish Health

Moderately Similar
1 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency
Similarity Score30%

Charlie Strange, MD

Medical University of South Carolina

Moderately Similar
6 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency

Worked with same sponsors:

Alpha-1 FoundationNational Center for Research Resources (NCRR)+1 more
Similarity Score30%

Rob Janssen, MD, PhD

Canisius-Wilhelmina Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency
Similarity Score30%

John Magee, MD

University of Michigan

Moderately Similar
3 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency
Similarity Score30%

Thomas Bowman, MD

Dicerna Pharmaceuticals

Moderately Similar
2 trials

Shared therapeutic areas:

alpha 1-Antitrypsin Deficiency
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00377416Early Phase 1PrincipalInvestigator

Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency

Alpha 1-Antitrypsin Deficiency
Completed
NCT00430768Phase 1PrincipalInvestigator

Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency

Alpha 1-Antitrypsin Deficiency
Completed

All 2 trials loaded